Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v17-EN Version v16-FR
Language English French
Date Updated 2019-09-18 2019-09-17
Drug Identification Number 02230736 02230736
Brand name MYLAN-MINOCYCLINE MYLAN-MINOCYCLINE
Common or Proper name MINOCYCLINE MINOCYCLINE
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients MINOCYCLINE MINOCYCLINE
Strength(s) 100MG 100MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100BT, 250BT 100BT, 250BT
ATC code J01AA J01AA
ATC description TETRACYCLINES TETRACYCLINES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2018-12-31 2018-12-31
Actual discontinuation date 2019-09-17 2019-09-17
Remaining supply date 2019-09-17 2019-09-17
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Discontinued in Shortage ID 7046 and 5919. Last lot 3053902 exp 2019-04-30 Discontinued in Shortage ID 7046 and 5919. Last lot 3053902 exp 2019-04-30
Health Canada comments